Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapyHUO, Teh-La; HUANG, Yi-Hsiang; SU, Chien-Wei et al.Clinical transplantation. 2008, Vol 22, Num 4, pp 469-475, issn 0902-0063, 7 p.Article

Selecting a Short-term Prognostic Model for Hepatocellular Carcinoma: Comparison Between the Model for End-stage Liver Disease (MELD), MELD-sodium, and Five Cancer Staging SystemsHUO, Teh-La; HSIA, Cheng-Yuan; HUANG, Yi-Hsiang et al.Journal of clinical gastroenterology. 2009, Vol 43, Num 8, pp 773-781, issn 0192-0790, 9 p.Article

Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy : Is there a lead-time bias?HUO, Teh-Ia; HUANG, Yi-Hsiang; CHIANG, Jen-Huei et al.Scandinavian journal of gastroenterology. 2007, Vol 42, Num 4, pp 485-492, issn 0036-5521, 8 p.Article

Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromesLUO, Jiing-Chyuan; HWANG, Shinn-Jang; WU, Jaw-Ching et al.Hepato-gastroenterology. 2002, Vol 49, Num 47, pp 1315-1319, issn 0172-6390Article